scispace - formally typeset
E

Emily K. Crispell

Researcher at Emory University

Publications -  18
Citations -  844

Emily K. Crispell is an academic researcher from Emory University. The author has contributed to research in topics: Methicillin-resistant Staphylococcus aureus & Staphylococcus aureus. The author has an hindex of 13, co-authored 18 publications receiving 712 citations. Previous affiliations of Emily K. Crispell include Women & Children's Hospital of Buffalo & Yerkes National Primate Research Center.

Papers
More filters
Journal ArticleDOI

Antibiotic failure mediated by a resistant subpopulation in Enterobacter cloacae

TL;DR: The ability of low-frequency bacterial subpopulations to contribute to clinically relevant antibiotic resistance is demonstrated, elucidating an enigmatic cause of antibiotic treatment failure and highlighting the critical need for more sensitive diagnostics.
Journal ArticleDOI

Dissecting vancomycin-intermediate resistance in staphylococcus aureus using genome-wide association.

TL;DR: This study demonstrated the power of GWAS for identifying common genetic variants associated with antibiotic resistance in bacteria and that rare mutations in candidate gene, identified using large genomic data sets, can also be associated with resistance phenotypes.
Journal ArticleDOI

Antimicrobial Peptide Resistance Mechanisms of Gram-Positive Bacteria.

TL;DR: Understanding the mechanisms of AMP resistance in Gram-positive species can provide guidelines in developing and applying AMPs as therapeutics, and offer insight into the role of resistance in bacterial pathogenesis.
Journal ArticleDOI

Detection of Staphylococcus aureus Isolates with Heterogeneous Intermediate-Level Resistance to Vancomycin in the United States

TL;DR: The data suggest that the overall prevalence of hVISA in the United States is low (0.3%) and the rates of resistance were as follows: oxacillin, 82; erythromycin, 82%; clindamycin, 73%; levofloxacin, 73; trimethoprim-sulfamethoxazole, 9%; and daptomycin, 9%.